Table 3.
Post-transplantation outcomes of patients who underwent transplantation for anti-GBM disease (except for recurrence)
| Acute rejection, n (%) | 22 (43) |
| Complications, n (%) | |
| Cardiac | 13 (25) |
| Hypertension | 39 (74) |
| Neoplasia | 14 (27) |
| NODAT | 9 (17) |
| Infection | 37 (70) |
| Loss of first graft, n (%) | |
| Rejection | 12 (23) |
| Recurrence | 1 (1,9) |
| Renal vein thrombosis | 1 (1,9) |
| Infection | 1 (1,9) |
| NA | 1 (1,9) |
| Death, n (%) | 3 (5,7) |
| Kidney re-transplanted for second/third time, n | 7/1 |
| Follow-up, mo, median (P25−P75) | 122 (60−213) |
NA, not available; NODAT, new-onset diabetes after transplantation; P25−P75, 25th−75th percentile.